Elite Pharmaceuticals, Inc. (ELTP)
0.46
-0.01
(-2.03%)
USD |
OTCM |
Jan 20, 09:47
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 494.27M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -4.56% |
| Valuation | |
| PE Ratio | 82.14 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.067 |
| Price to Book Value | 8.025 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.1022 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 87.92% |
Profile
| Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications and New Drug Applications segments. The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ. |
| URL | http://www.elitepharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 12, 2026 (est.) |
| Last Earnings Release | Nov. 14, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications and New Drug Applications segments. The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ. |
| URL | http://www.elitepharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 12, 2026 (est.) |
| Last Earnings Release | Nov. 14, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |